<DOC>
	<DOCNO>NCT02241174</DOCNO>
	<brief_summary>This study determine safety efficacy dilute bleach bath solution final rinse reduction Staphylococcus aureus colonization among child adult Filipinos mild moderate atopic dermatitis..</brief_summary>
	<brief_title>0.005 % Sodium Hypochlorite Final Rinse Solution Atopic Dermatitis</brief_title>
	<detailed_description>Objective : To determine safety efficacy 0.005 % sodium hypochlorite final rinse solution reduction Staphylococcus aureus colonization among child adult Filipinos mild moderate atopic dermatitis . Design : Randomized , double blind , control clinical trial . Setting : Makati Medical Center , Dermatology Outpatient Department Participants : Patients mild moderate atopic dermatitis , see Makati Medical Center Dermatology Outpatient Department . Sample size : 68 ( 34 treatment group , 34 placebo group ) Intervention : Eligible patient randomly allocate two group . The subject either treatment group ( 0.005 % sodium hypochlorite ) placebo group ( bath water ) . Subjects use liter 0.005 % sodium hypochlorite final rinse solution bath treatment group liter bath water placebo group . This intervention do twice week 12 week . Both patient assessor blind treatment assignment . Assessment Outcome : The outcome assess week 4 12 . Primary outcome measure use culture finding , physician 's global assessment ( PGA ) severity disease eczema area severity index ( EASI ) score . Secondary outcome measure assess adverse effect follow-up week 4 12 . Data Analysis : Kruskal-Wallis Test use compare significant difference score two group Wilcoxon Signed Rank Test use compare significant difference score within group .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Sodium Hypochlorite</mesh_term>
	<mesh_term>Eusol</mesh_term>
	<criteria>1 . Males females 8 year old . 2 . Subjects clinical diagnosis atopic dermatitis ( base Hannifin Rajka criterion ) . 3 . Healthy subject skin disease . 4 . Subjects without prior topical oral antibiotic two week prior enrollment period . Those undergone course topical oral antibiotic give least 2 week washout period . 1 . Severe Atopic dermatitis require hospitalization . 2 . Hospitalized debilitated patient . 3 . Subjects serious skin disorder , pigmentation extensive scarring affect area . 4 . Subjects know history clinically relevant allergy , particular chlorine contain compound . 5 . Pregnant woman nurse mother . 6 . Subjects situation , , opinion investigator , may interfere optimal participation study . 7 . Subjects participate participate clinical trial within 1 month enrollment study . 8 . Subjects communicate investigator ( &gt; 18 year old ) unaccompanied parent legal guardian ( &lt; 18 year old ) . 9 . Subjects unable followup .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Atopic Dermatitis</keyword>
</DOC>